Table 3

2-Year Clinical Outcome Between Men and Women

Women
(n = 871)
Men
(n = 2,326)
Difference
(95% CI)
Adjusted HR
(95% CI)
p Value
Death
 Any cause39 (4.5)80 (3.4)1.0 (−0.4 to 2.5)1.02 (0.69–1.52)0.92
 Cardiac cause23 (2.6)46 (2.0)0.7 (−0.5 to 1.8)1.11 (0.66–1.88)0.69
POCE129 (14.8)331 (14.2)0.6 (−2.1 to 3.3)1.02 (0.83–1.26)0.82
MI
 Any MI32 (3.7)92 (3.9)−0.3 (−1.8 to 1.2)0.99 (0.66–1.48)0.95
 Target vessel-related MI30 (3.4)84 (3.6)−0.2 (−1.6 to 1.3)1.00 (0.66–1.52)0.99
Revascularization
 Any revascularization74 (8.5)201 (8.6)−0.1 (−2.3 to 2.1)1.07 (0.81–1.40)0.64
 TVR38 (4.4)122 (5.2)−0.9 (−2.6 to 0.8)0.97 (0.67–1.41)0.88
 TLR31 (3.6)87 (3.7)−0.2 (−1.6 to 1.3)1.12 (0.74–1.71)0.59
TVF82 (9.4)222 (9.5)−0.1 (−2.4 to 2.2)1.03 (0.79–1.34)0.82
TLF§76 (8.7)196 (8.4)0.3 (−1.9 to 2.5)1.10 (0.85–1.45)0.44
Major adverse cardiac events91 (10.4)236 (10.1)0.3 (−2.0 to 2.7)1.04 (0.81–1.33)0.78
Stent thrombosis
 Definite4 (0.5)18 (0.8)−0.3 (−1.0 to 0.3)0.76 (0.25–2.28)0.63
 Definite or probable11 (1.3)27 (1.2)0.1 (−0.7 to 0.9)1.19 (0.59–2.41)0.62

Values are n (%).

∗HR adjusted for age, clinical syndrome, trial (i.e., TWENTE or DUTCH PEERS), diabetes, hypertension, previous percutaneous coronary intervention or coronary artery bypass grafting, and previous MI using a Cox regression model.

CI = confidence interval; HR = hazard ratio; MI = myocardial infarction; POCE = patient-oriented composite endpoint; TLF = target lesion failure; TLR = target lesion revascularization; TVF = target vessel failure; TVR = target vessel revascularization.

  • POCE is a composite of all cause death, any MI, or any revascularization.

  • TVF is a composite of cardiac death, target vessel-related MI, or clinically indicated TVR.

  • § TLF is a composite of cardiac death, target vessel-related MI, or clinically indicated TLR.

  • Major adverse cardiac events is a composite of all cause death, any MI, emergent coronary-artery bypass surgery, or clinically indicated TLR.